Esperion Therapeutics
ESPR
#6552
Rank
S$0.94 B
Marketcap
S$3.99
Share price
-12.82%
Change (1 day)
27.50%
Change (1 year)

P/S ratio for Esperion Therapeutics (ESPR)

P/S ratio as of January 2026 (TTM): 2.77

According to Esperion Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -1.86. At the end of 2025 the company had a P/S ratio of 1.76.

P/S ratio history for Esperion Therapeutics from 2013 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20251.7630.1%
20241.35-53.75%
20232.92-51.95%
20226.0856.69%
20213.8831.08%
20202.96-73.21%
201911.1
2018N/A
2017N/A
2016N/A
2015N/A
2014N/A
2013N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Ultragenyx Pharmaceutical
RARE
3.73 34.59%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
3.58 29.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
2.29-17.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
5.71 106.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
7.38 166.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
6.05 118.44%๐Ÿ‡บ๐Ÿ‡ธ USA